Starten Sie Ihre Suche...


Durch die Nutzung unserer Webseite erklären Sie sich damit einverstanden, dass wir Cookies verwenden. Weitere Informationen
Publikationen
Ergebnisse pro Seite:  10



Neu, Marie Astrid; Stoessell, Sandra; Wingerter, Arthur et al.

Associated Factors to Reduced Physical Activity in Long-Term Childhood Cancer Survivors in Germany

ONCOLOGY RESEARCH AND TREATMENT. Bd. 43. 2020 S. 238-238


Klapdor, Rudiger; Hillemanns, Peter; Woelber, Linn et al.

Association between obesity and vulvar cancer recurrence: an analysis of the AGO-CaRE-1 study

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. Bd. 30. H. 7. 2020 S. 920-926



Rosner, Ann K.; Closs, Ellen I.; Habermeier, Alice et al.

Asymmetric dimethylarginine (ADMA) in retinal vein occlusion-Results from the Gutenberg RVO study

OPHTHALMOLOGE. 2020


Galle, Peter R.; Cheng, Ann-Lll; Qin, Shukui et al.

Atezolizumab (ATEZO) plus Bevacizumab ( BEV) vs Sorafenib (SOR) in Patients (PTS) with Unresectable Hepatocellular Carcinoma (HCC): Phase 3 Results from Imbrave150

ONCOLOGY RESEARCH AND TREATMENT. Bd. 43. 2020 S. 220-220


Finn, Richard S.; Qin, Shukui; Ikeda, Masafumi et al.

Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma

NEW ENGLAND JOURNAL OF MEDICINE. Bd. 382. H. 20. 2020 S. 1894-1905


Matos-Rodrigues, Gabriel E.; Grigaravicius, Paulius; Lopez, Bernard S. et al.

ATRIP protects progenitor cells against DNA damage in vivo

CELL DEATH & DISEASE. Bd. 11. H. 10. 2020


Matos-Rodrigues, Gabriel E.; Grigaravicius, Paulius; Lopez, Bernard S. et al.

ATRIP protects progenitor cells against DNA damage in vivo (vol 11, 923, 2020)

CELL DEATH & DISEASE. Bd. 11. H. 12. 2020